Antagonizing the cannabinoid receptor Type 1: A dual way to fight obesity

Journal of Endocrinological Investigation

Volumn 26, Issue 10, 2003, Pages 1041-1044

  Cota, D ^a   Genghini, S ^b   Pasquali, R ^b   Pagotto, U ^b  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

CB1; Endogenous cannabinoid system; Energy balance; Obesity; Rimonabant

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N MORPHOLINO 1H PYRAZOLE 3 CARBOXAMIDE; ADIPONECTIN; AJULEMIC ACID; ANANDAMIDE; CANNABINOID 1 RECEPTOR; CANNABINOID 1 RECEPTOR ANTAGONIST; CANNABINOID RECEPTOR AGONIST; CANNABINOID RECEPTOR ANTAGONIST; CANNABIS; CELL NUCLEUS RECEPTOR; FATTY ACID; INSULIN; MELANIN CONCENTRATING HORMONE; NEUROPEPTIDE Y; OREXIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; RIMONABANT; UNCLASSIFIED DRUG;

ANOREXIA; ATHEROSCLEROSIS; BODY WEIGHT; CANCER; CENTRAL NERVOUS SYSTEM FUNCTION; CLINICAL TRIAL; DRUG EFFECT; DYSLIPIDEMIA; EATING DISORDER; ENERGY BALANCE; FOOD INTAKE; GASTROINTESTINAL MOTILITY; HUMAN; HUNGER; HYPERPHAGIA; HYPOPHAGIA; INCREASED APPETITE; INSULIN SENSITIVITY; METABOLIC ACTIVATION; NAUSEA; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PERIPHERAL CIRCULATION; PERISTALSIS; REVIEW; STOMACH EMPTYING; WASTING SYNDROME; WEIGHT GAIN;

EID: 0346368466     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03348205     Document Type: Review

References (17)

1. Hill JO, Wyatt HR, Reed GW, Peters JC. Obesity and the environment: Where do we go from here? Science 2003, 299: 853-5.
2. Marx J. Cellular warriors at the battle of the bulge. Science 2003, 299: 846-9.
3. Gura T. Obesity drug pipeline not so fat. Science 2003, 299: 849-52.
4. Howlett AC, Barth F, Bonner TI, et al. International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol Rev 2002, 54: 161-202.
5. Kirkham TC, Williams CM. Endogenous cannabinoids and appetite. Nutr Res Rev 2001, 14: 65-86.
6. Cota D, Marsicano G, Lutz B, et al. The endogenous cannabinoid system as a modulator of food intake. Int J Obes Relat Metab Disord 2003, 27: 289-301.
7. Werner NA, Koch JE. Effects of the cannabinoid antagonists AM281 and AM630 on deprivation-induced intake in Lewis rats. Brain Res 2003, 967: 290-2.
8. Di Marzo V, Goparaju SK, Wang L, et al. Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature 2001, 410: 822-5.
9. Kirkham TC, Williams CM, Fezza F, Di Marzo V. Endocannabinoid leves in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: Stimulation of eating by 2-archidonoyl glycerol. Br J Pharmacol 2002, 136: 550-7.
10. Harrold JA, Elliott JC, King PJ, Widdowson PS, Williams G. Down-regulation of cannabinoid-1 (CB-1) receptors in specific extrahypothalamic regions of rats with dietary obesity: A role for endogenous cannabinoids in driving appetite for palatable food? Brain Res 2002, 952: 232-8.
11. Cota D, Marsicano G, Tschöp M, et al. The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis. J Clin Invest 2003, 112: 423-31.
12. Gomez R, Navarro M, Ferrer B, et al. A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding. J Neurosci 2002, 22: 9612-7.
13. Ravinet TC, Arnone M, Delgorge C, et al. Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice. Am J Physiol Regul Integr Comp Physiol 2003, 284: R345-53.
14. Hildebrandt AL, Kelly-Sullivan DM, Black SC. Antiobesity effects of einem diabetikerchronic cannabinoid CB1 receptor antagonist treatment in diet-induced obese mice. Eur J Pharmacol 2003, 462: 125-32.
15. Lyon CJ, Law RE, Hsueh WA. Minireview: Adiposity, inflammation, and atherogenesis. Endocrinology 2003, 144: 2195-200.
16. Liu J, Li H, Burstein SH, Zurier RB, Chen JD. Activation and binding of peroxisome proliferator-activated receptor gamma by synthetic cannabinoid ajulemic acid. Mol Pharmacol 2003, 63: 983-92.
17. Bensaid M, Gary-Bobo M, Esclangon A, et al. The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells. Mol Pharmacol 2003, 63: 908-14.